J. Rodrigo Mora
CSO,
BreezeBio
Physician-scientist and R&D executive with more than a decade leading discovery and translational organizations across large pharma and venture-backed biotech, built on a Harvard Medical School faculty career in immunology. Currently CSO at BreezeBio, setting strategy for a tolerogenic nanoparticle platform in autoimmune disease. Prior VP and platform immunology head at Moderna, therapeutic-area clinical lead at Takeda, and immunology disease-biology lead at Janssen. Track record spanning target identification through IND and Phase 1/2 clinical leadership, with deep expertise in immune tolerance and NP-mRNA delivery.
Sessions
-
19-Jan-2027Theatre 3Session 2: Non-viral delivery Part 1 - R&D and Regulatory focus